The document summarizes a study that evaluated the alpha amylase inhibitory effect of the hydroalcoholic extract of Sida acuta. The extract was tested against porcine pancreatic alpha amylase using an in vitro assay. The inhibitory concentration (IC50) of the Sida acuta extract was found to be 17.10μg/ml, compared to 9.27μg/ml for the positive control acarbose. This suggests that the Sida acuta extract has significant alpha amylase inhibitory activity, though less potent than acarbose. The study concludes that preparations of Sida acuta may be useful as an adjuvant therapy for diabetes management due to its mild antidiabetic effects.